Skip to main content

A Conversation with FDA’s Center for Tobacco Products Director Dr. Brian King and Truth Initiative CEO and President Robin Koval

Join Truth Initiative for a virtual discussion and Q&A with the Director of FDA’s Center for Tobacco Products on the Center’s vision for the regulation of tobacco products.

November 8, 2022 | On Demand

Major regulatory initiatives to reduce tobacco-related disease and death are in progress at the Food and Drug Administration’s Center for Tobacco Products (CTP). CTP is continuing the rulemaking process for its proposed rules to remove menthol cigarettes and flavored cigars from the market, reviewing premarket tobacco product applications from e-cigarette manufacturers, and planning to propose a rule to reduce nicotine in cigarettes and other combusted tobacco products to non-addictive levels. At a critical time for our nation’s youth and the millions of adult tobacco users who want to quit, this Truth Initiative Impact Series will explore some of the most pressing issues facing CTP.

Join Dr. King and Truth Initiative President and CEO Robin Koval for an intimate conversation on CTP’s vision for the future regulation of tobacco products.

Impact Series Logo

Truth Initiative Impact Series

The Truth Initiative Impact Series is a robust, recurring event that brings together key stakeholders and experts to engage in thought-provoking conversations about ways we can innovate and inspire action to achieve a culture where young people reject smoking, vaping, and nicotine. The goal of this thought leadership series is to convene diverse partners in tobacco control and other public health organizations, parents, teachers, and policy makers, who can benefit from Truth Initiative’s work.